©The Author(s) 2004.
World J Gastroenterol. Oct 1, 2004; 10(19): 2795-2799
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2795
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2795
Table 1 Relationship between the HPA expression and the clinicopathological parameters of HCC
| Items | Number | HPA positive | HPA negative | P value |
| Size of tumor | ||||
| > 5 cm | 25 | 13 | 12 | 0.250 |
| ≤ 5 cm | 8 | 3 | 5 | |
| Tumor capsule | ||||
| Integrated | 14 | 5 | 9 | 0.130 |
| Disintegrated | 19 | 11 | 8 | |
| AFP | ||||
| Positive | 21 | 12 | 9 | 0.125 |
| Negative | 12 | 4 | 8 | |
| HBsAg | ||||
| Positive | 24 | 12 | 12 | 0.292 |
| Negative | 9 | 4 | 5 | |
| Liver cirrhosis | ||||
| Yes | 18 | 8 | 10 | 0.241 |
| No | 15 | 8 | 7 | |
| Edmondson grade | ||||
| I, II | 13 | 3 | 10 | 0.019 |
| III, IV | 20 | 13 | 7 | |
| TNM staging | ||||
| I, II | 18 | 6 | 12 | 0.047 |
| III, IV | 15 | 10 | 5 |
- Citation: Chen XP, Liu YB, Rui J, Peng SY, Peng CH, Zhou ZY, Shi LH, Shen HW, Xu B. Heparanase mRNA expression and point mutation in hepatocellular carcinoma. World J Gastroenterol 2004; 10(19): 2795-2799
- URL: https://www.wjgnet.com/1007-9327/full/v10/i19/2795.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i19.2795